Testosterone patches in the management of patients with mild/moderate systemic lupus erythematosus.

@article{Gordon2008TestosteronePI,
  title={Testosterone patches in the management of patients with mild/moderate systemic lupus erythematosus.},
  author={Caroline Gordon and Daniel Wallace and Shuntaro Shinada and Kenneth Carekin Kalunian and Lindsy J. Forbess and Glenn D Braunstein and Michael H. Weisman},
  journal={Rheumatology},
  year={2008},
  volume={47 3},
  pages={334-8}
}
OBJECTIVES Androgen deficiency has been associated with the development of systemic lupus erythematosus (SLE). The aim of this study was to test the efficacy of testosterone patches vs placebo in female SLE patients with baseline mild-to-moderate disease activity in a randomized, double-blind, single-centre placebo-controlled trial. METHODS Patients received testosterone (150 microg) or placebo transdermal patches for 12 weeks. Patients were assessed at 4-weekly intervals for disease activity… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 12 extracted citations

Similar Papers

Loading similar papers…